Metagenomi Therapeutics, Inc. MGX
0.61 USD -0.02 (-2.85%)
Regular-session close
0.61 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
0.61 Day range 0.6423
0.60 52-week range 1.87
- YTD
- -62.11%
- 1 year
- -61.88%
Benzinga news
benzinga.com Metagenomi Therapeutics Receives FDA Clearance For Its Investigational New Drug Application For MGX-001 To Treat Hemophilia A Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the "Company"), an in vivo genome editing company capitalizing on its proprietary technologies to create potentially curative genetic medicines for…
benzinga.com Metagenomi Therapeutics To Present Presentation On Preclinical Data Of MGX-001 At 68th American Society Of Hematology Annual Meeting Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the "Company"), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 17.9% to $0.16 during Monday's after-market session. The market value of their outstanding shares is at $2.8 million. SCWorx (NASDAQ:WORX)…
